comparemela.com
  1. Home
  2. Live Updates
  3. Oncolytic Herpes Simplex Virus - Breaking News

Latest Breaking News On - Oncolytic herpes simplex virus - Page 1 : comparemela.com

ImmVira enters clinical development in combination therapy of MVR-T3011 IT and MEK inhibitor in the U S

SHENZHEN, China, April 19, 2022 /PRNewswire/ ImmVira announced that, company has reached a cooperation agreement with Roche to establish clinic.

United statesPrnewsfoto immviraPrnewswire immviraTherapeutic efficacyOncolytic herpes simplex virusMutated colorectalLung carcinomaGrace zhou

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.